Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tooth surface biofilm bacteria encompass highly diverse, structured polymicrobial communities that colonize tooth surfaces and form dental plaque, a resilient biofilm composed of hundreds of microbial species embedded in extracellular polymeric substances. Early colonizers (e.g., Streptococcus spp., Actinomyces spp.) adhere to the acquired pellicle, followed by succession and incorporation of other taxa (e.g., Veillonella, Fusobacterium, and Porphyromonas). These bacterial consortia are central to oral health and disease, implicated in dental caries (via acidogenic and aciduric species) and periodontal diseases (via pathogenic biofilm shifts). The unique physical structure of biofilms confers resistance to antimicrobials and immune defenses, making them a major clinical challenge.
Disruption of bacterial cell walls/membranes; Inhibition of bacterial adhesion and colonization; Biofilm matrix degradation (via enzymes or physical methods); Quorum-sensing inhibition; Oxidative killing (e.g., photodynamic therapy, cold plasma)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on null.